NCT06273371 - Tolerance and Growth Outcomes in Children Diagnosed With Cow's Milk Protein Allergy and Prescribed an Extensively Hydrolyzed Casein Formula (Damira 2000©) in Spain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

December 21, 2023

Study Completion Date

December 21, 2023

Conditions

Cow's Milk Protein Allergy

Interventions

OTHER

Damira 2000 Infant formula

100% extensive casein hydrolysate Infant formula

Trial Locations (8)

Hospital Quirónsalud de Córdoba, Córdoba

H. Virgen del Rocío, Seville

H. Virgen Macarena, Seville

Instituto Hispalense de pediatría, Seville

Hospital Materno infantil de Ourense, Ourense

H. Clínico de Santiago, Santiago de Compostela

Clínica privada Dr. Romera, Madrid

Fundación Jiménez Día, Madrid